Cabaletta Bio (CABA) Capital Expenditures (2019 - 2025)

Cabaletta Bio's Capital Expenditures history runs 7 years deep, the most recent figure standing at -$1.0 million for Q4 2025.

• In Q4 2025, Capital Expenditures fell 372.34% year-over-year to -$1.0 million; the TTM figure through Sep 2025 stood at $1.4 million (down 31.2% YoY), while the FY2024 annual figure was $2.2 million, up 214.96% from the prior year.
• Capital Expenditures was -$1.0 million for Q4 2025 at Cabaletta Bio, down from $981000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.7 million in Q3 2022 to a low of -$2.1 million in Q4 2022.
• Historically, Capital Expenditures has averaged $214684.2 across 5 years, with a median of $200000.0 in 2023.
• Biggest YoY gain for Capital Expenditures was 2146.15% in 2024; the steepest drop was 603.51% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $1.1 million in 2021, then tumbled by 296.06% to -$2.1 million in 2022, then jumped by 109.36% to $200000.0 in 2023, then jumped by 88.0% to $376000.0 in 2024, then tumbled by 372.34% to -$1.0 million in 2025.
• The last three Capital Expenditures figures came in at -$1.0 million (Q4 2025), $981000.0 (Q3 2025), and $43000.0 (Q2 2025), per Business Quant data.